Medical enigma probed by Hebrew University researchers

The healing element is also the enemy

2013-04-03

(Press-News.org) Jerusalem, April 3, 2013 – The same factor in our immune system that is instrumental in enabling us to fight off severe and dangerous inflammatory ailments is also a player in doing the opposite at a later stage, causing the suppression of our immune response.

Why and how this happens and what can be done to mediate this process for the benefit of mankind is the subject of an article published online in the journal Immunity by Ph.D. student Moshe Sade-Feldman and Prof. Michal Baniyash of the Lautenberg Center for General and Tumor Immunology at the Institute for Medical Research Israel-Canada at the Hebrew University Faculty of Medicine.

Chronic inflammation poses a major global health problem and is common to different pathologies -- such as autoimmune diseases (diabetes, rheumatoid arthritis, lupus and Crohn's), chronic inflammatory disorders, chronic infections (HIV, leprosy, leishmaniasis) and cancer. Cumulative data indicate that at a certain stage of each of these diseases, the immune system becomes suppressed and results in disease progression.

In their previous work, the Hebrew University researchers had shown that in the course of chronic inflammation, unique immune system cells with suppressive features termed myeloid derived suppressor cells (MDSCs) are generated in the bone marrow and migrate into the body's organs and blood, imposing a general immune suppression.

A complex network of inflammatory compounds persistently secreted by the body's normal or cancerous cells support MDSC accumulation, activation and suppressive functions. One of these compounds is tumor necrosis factor-a (TNF-a), which under acute immune responses (short episodes), displays beneficial effects in the initiation of immune responses directed against invading pathogens and tumor cells.

However, TNF-a also displays harmful features under chronic responses, as described in pathologies such as rheumatoid arthritis, psoriasis, type II diabetes, Crohn's disease and cancer, leading to complications and disease progression. Therefore, today several FDA- approved TNF-a blocking reagents are used in the clinic for the treatment of such pathologies.

What has remained unclear until now, however, is just how TNF-a plays its deleterious role in manipulating the host's immune system towards the generation of a suppressive environment.

In their work, the Hebrew University researchers discovered the mechanisms underlying the TNF-a function, a key to controlling this factor and manipulating it, perhaps, for the benefit of humans. Using experimental mouse models, they showed unequivocally how TNF-a is critical in the induction of immune suppression generated during chronic inflammation. The TNF-a was seen to directly affect the accumulation and suppressive function of MDSCs, leading to an impaired host's immune responses as reflected by the inability to respond against invading pathogens or against developing tumors.

Further, the direct role of how TNF-a works in humans was mimicked by injecting the FDA-approved anti-TNF-a drug, etanercept, into mice at the exacerbated stage of an inflammatory response, when MDSC accumulation was observed in the blood. The etanercept treatment changed the features of MDSCs and abolished their suppressive activity, leading to the restoration of the host's immune function.

Taken together, the results show clearly how the TNF-a-mediated inflammatory response, whether acute or chronic, will dictate its beneficial or harmful consequence on the immune system. While during acute inflammation TNF-a is vital for immediate immune defense against pathogens and clearance of tumor cells, during chronic inflammation -- under conditions where the host is unable to clear the pathogen or the tumor cells -- TNF-a is harmful due to the induction of immune suppression.

These results, providing new insight into the relationship between TNF-a and the development of an immune suppression during chronic inflammation, may aid in the generation of better therapeutic strategies against various pathologies when elevated TNF-a and MDSC levels are detected, as seen, for example, in tumor growths.

INFORMATION:

ELSE PRESS RELEASES FROM THIS DATE:

Largest class survey reveals polarised UK society and the rise of new groups

2013-04-03

The largest survey of the British class system ever carried out has revealed a new structure of seven social divisions, ranging from an "advantaged and privileged" elite to a large "precariat" of poor and deprived people. The British Sociological Association's annual conference in London heard today [Wednesday 3 April 2013] that the survey, of over 150,000 people, revealed a collapse in the number of traditional working class, and the rise of five new classes. Professor Mike Savage, of the London School of Economics and Political Science (LSE), and Professor Fiona Devine, ...

Building quantum states with individual silicon atoms

2013-04-03

By introducing individual silicon atom 'defects' using a scanning tunnelling microscope, scientists at the London Centre for Nanotechnology have coupled single atoms to form quantum states. Published today in Nature Communications, the study demonstrates the viability of engineering atomic-scale quantum states on the surface of silicon – an important step toward the fabrication of devices at the single-atom limit. Advances in atomic physics now allow single ions to be brought together to form quantum coherent states. However, to build coupled atomic systems in large ...

Brain Activity Mapping Project aims to understand the brain

2013-04-03

The scientific tools are not yet available to build a comprehensive map of the activity in the most complicated 3 pounds of material in the world — the human brain, scientists say in a newly published article. It describes the technologies that could be applied and developed for the Brain Activity Mapping (BAM) Project, which aims to do for the brain what the Human Genome Project did for genetics. Published in the journal ACS Nano, the article describes how BAM could bring new understanding of how the brain works and possibly lead to treatments of clinical depression, ...

Same-day water pollution test could keep beaches open more often

2013-04-03

With warm summer days at the beach on the minds of millions of winter-weary people, scientists are reporting that use of a new water quality test this year could prevent unnecessary beach closures while better protecting the health of swimmers. A study analyzing the accuracy of the test appears in ACS' journal Environmental Science & Technology. Meredith B. Nevers and colleagues point out that decisions on whether water is safe for recreational use have been based on tests that actually show the condition of water in the past. Those tests involve sampling water for the ...

Effectiveness of a spray that greatly improves dry mouth sensation caused by anti-depressants

2013-04-03

Researchers from the universities of Granada and Murcia have confirmed the effectiveness of a spray containing 1% malic acid, which greatly improves xerostomy, or dry mouth, caused by anti-depressant drugs. This product, combined with xylitol and fluorides, in a spray format, stimulates saliva production in patients with this illness, thus improving their quality of life. Xerostomy is a dry-mouth sensation that patients have, often caused by reduced salivary secretion or biochemical changes in the saliva itself. Patients with xerostomy often find difficulty in chewing, ...

CWRU-led scientists build material that mimics squid beak

2013-04-03

Researchers led by scientists at Case Western Reserve University have turned to an unlikely model to make medical devices safer and more comfortable—a squid's beak. Many medical implants require hard materials that have to connect to or pass through soft body tissue. This mechanical mismatch leads to problems such as skin breakdown at abdominal feeding tubes in stroke patients and where wires pass through the chest to power assistive heart pumps. Enter the squid. The tip of a squid's beak is harder than human teeth, but the base is as soft as the animal's Jello-like ...

Verifying that sorghum is a new safe grain for people with celiac disease

2013-04-03

Strong new biochemical evidence exists showing that the cereal grain sorghum is a safe food for people with celiac disease, who must avoid wheat and certain other grains, scientists are reporting. Their study, which includes molecular evidence that sorghum lacks the proteins toxic to people with celiac disease, appears in ACS' Journal of Agricultural and Food Chemistry. Paola Pontieri and colleagues explain that those gluten proteins, present in wheat and barley, trigger an immune reaction in people with celiac disease that can cause abdominal pain and discomfort, constipation, ...

Earth is 'lazy' when forming faults like those near San Andreas

2013-04-03

AMHERST, Mass. – Geoscientist Michele Cooke and colleagues at the University of Massachusetts Amherst take an uncommon, "Earth is lazy" approach to modeling fault development in the crust that is providing new insights into how faults grow. In particular, they study irregularities along strike-slip faults, the active zones where plates slip past each other such as at the San Andreas Fault of southern California. Until now there has been a great deal of uncertainty among geologists about the factors that govern how new faults grow in regions where one plate slides past ...

New view of origins of eye diseases

2013-04-03

Using new technology and new approaches, researchers at Lund University in Sweden hope to be able to explain why people suffer vision loss in eye diseases such as retinal detachment and glaucoma. Research on diseases of the eye such as retinal detachment and glaucoma has until now focused on the biochemical process that takes place in the eye in connection with the diseases. Fredrik Ghosh and Linnéa Taylor have concentrated instead on attempting to understand what happens on a biomechanical level in the diseases and have produced results that have drawn a lot of interest ...

Taken under the 'wing' of the small magellanic cloud

2013-04-03

The Small Magellanic Cloud (SMC) is one of the Milky Way's closest galactic neighbors. Even though it is a small, or so-called dwarf galaxy, the SMC is so bright that it is visible to the unaided eye from the Southern Hemisphere and near the equator. Many navigators, including Ferdinand Magellan who lends his name to the SMC, used it to help find their way across the oceans. Modern astronomers are also interested in studying the SMC (and its cousin, the Large Magellanic Cloud), but for very different reasons. Because the SMC is so close and bright, it offers an opportunity ...

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Medical enigma probed by Hebrew University researchers

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: